Baudax Bio, Inc. BXRXQ
—
0.00
0.00
NaN
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow BXRXQ
Growth Flags
show if company had growth for consecutive years
| Sep '23 | Jun '23 | Mar '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
| 48.04% | 1,067.64% | (2,846.26%) | 1,067.45% |
+8 more TTM periods Free account |
|
| (37.56%) | (110.78%) | (123.78%) | (185.74%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
50.94% | 232.36% | 418.57% | 389.27% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(3.07) | (5.14) | (11.19) | (84.17) | |
Free Cash Flow |
(24.54) | (25.10) | (25.96) | (27.94) | |
Capital Expenditures |
(0.17) | — | — | (0.15) | |
| Other line items | |||||
Cash ROIC |
524.55% | 737.71% | (661.71%) | 234.26% | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
3.41 | 0.73 | 0.75 | 0.47 | |
Depreciation/Fixed assets |
0.62 | 0.57 | 2,151.00 | 240.22 | |
Capex/Depreciation |
(0.07) | 0.00 | 0.00 | (0.07) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.05) | (5.14) | (11.19) | (83.71) | |
Capex per Share |
(0.02) | 0.00 | 0.00 | (0.45) | |
Capex to Sales |
0.00 | — | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates